Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
DexCom
DXCM
5
Collegium Pharmaceutical
COLL
US Stock MarketDetailed Quotes
TNFA TNF Pharmaceuticals
- 0.350
- -0.010-2.78%
Close Mar 31 16:00 ET
- 0.370
- +0.020+5.71%
Pre 08:09 ET
964.27KMarket Cap-0.03P/E (TTM)
0.370High0.338Low150.27KVolume0.349Open0.360Pre Close53.58KTurnover6.12%Turnover RatioLossP/E (Static)2.76MShares3.50052wk High0.06P/B858.89KFloat Cap0.32552wk Low--Dividend TTM2.45MShs Float6469632.000Historical High--Div YieldTTM8.91%Amplitude0.325Historical Low0.356Avg Price1Lot Size
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
TNF Pharmaceuticals Stock Forum
Breakthrough Oral Treatment for Muscle Loss: TNF Pharma Reports Positive Clinical Data
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; F...
Can This First-Ever Oral TNF Inhibitor Disrupt a $40 Billion Market? Phase 2b Trial Begins
TNF Pharmaceuticals Initiates Phase 2b Clinical Trial of First Oral TNF-Alpha Inhibitor
Tuesday, 25th February at 9:20 am
Fully funded multi-center study initiated at University of Florida to further explore efficacy of isomyosamine for preventing progressive muscle loss and frailty
Study builds on positive results achieved in earlier Phase 2a trial
TNF-alpha inhibitor market estimated at $40+ billion with no FDA-approved oral treatments
TNF Pharmaceuticals, In...
On watch not sure what's happening right now but like the AH chart. Don't want to get caught in a dump so will be looking at this one closely tomorrow morning.
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press r...
No comment yet